This will play a video - Downloadable brochure about the urgency of evaluating symptomatic aortic stenosis.

SYMPTOMATIC AORTIC STENOSIS CAN‘T WAIT

An urgent evaluation is everything.
DOWNLOAD BROCHURE
Alert Indications, Safety, and Warnings

250,000 SSAS PATIENTS

Today, 250,000 people in the U.S. are diagnosed annually with symptomatic severe aortic stenosis (SSAS).1-9

Medtronic TAVR covering 48% of those patients are undertreated nationally which equates to 120,000+ who remain untreated for symptomatic severe aortic stenosis (SAS).
Medtronic transcatheter aortic valve replacement (TAVR) infographic noting that once severe symptoms of symptomatic aortic stenosis appear, survival is cut short.
Photo of older man and woman and the woman resting her head on the man's shoulder.

MEDICAL MANAGEMENT ISN’T ENOUGH

After developing symptomatic severe aortic stenosis, the average patient survival is two years without treatment.11 

Photo of older male wearing glasses and smiling at the camera.

SYMPTOMATIC AORTIC STENOSIS CAN BE FATAL

Aortic stenosis is among the most common of all valvular heart diseases and continues to increase as our population ages.12 Symptomatic severe aortic stenosis (SSAS) can be fatal if left untreated.

EARLY DIAGNOSIS AND TREATMENT CAN MEAN BETTER OUTCOMES

Photo of a heart stethoscope laying flat on a surface with white background.

DUE TO THE FOLLOWING FACTORS, SSAS ISN'T ALWAYS EASY TO DIAGNOSE OR TREAT:

  • Heart murmurs go undetected.13
  • Referrals are delayed or too late.13
  • Echocardiogram findings are misclassified due to complex cardiac anatomy.13
  • Patients don't recognize or report their symptoms.14
  • Patients refuse treatment.15

Learn about determining the severity of aortic stenosis and when to refer patients to the heart team.
More information (see more) Less information (see less)

Experts share their experiences assessing and treating patients with severe aortic stenosis.
More information (see more) Less information (see less)

Medtronic TAVR graph noting the operated versus unoperated survival rates of aortic valve replacement over a 5-year span.

AORTIC VALVE REPLACEMENT GREATLY IMPROVES THE RATE OF SURVIVAL

Image of female doctor in white lab coat wearing a stethoscope.

Mortality difference for people with symptoms of aortic stenosis treated with aortic valve replacement versus those not undergoing this procedure is one of the most striking in medicine.12

URGENCY IS EVERYTHING FOR SYMPTOMATIC AORTIC STENOSIS PATIENTS

A checklist of how to recognize SSAS early on.

REFER YOUR SSAS PATIENTS TO THE HEART VALVE TEAM

FOLLOW UPDATED ACC/AHA GUIDELINES

"Patients with severe VHD should be evaluated by a multidisciplinary heart valve team when intervention is considered."

– ACC/AHA 2020 Guidelines

LEARN MORE
Photo of male doctor wearing a stethoscope smiling at a female patient.
Infographic showing 90 percent of heart disease patients are influenced by their doctor to get SSAS treatment.

UNDERSTANDING SYMPTOMATIC AORTIC STENOSIS FROM A PATIENT POINT OF VIEW

It's easier to help patients when you know what they're thinking. The insights gathered from a new national survey conducted by Heart-Valve-Surgery.com, with support from Medtronic, can help you better understand the heart valve patient experience.

VIEW THE SURVEY

Share this resource with your patients: Heart-Valve-Surgery.com can help them learn more about their condition and find a supportive community of other patients diagnosed with SSAS.

1

STS Adult Cardiac Database. 2010 Harvest, Isolated AVR.

2

Bach DS, Cimino N, Deeb GM. Unoperated patients with severe aortic stenosis. J Am Coll Cardiol. November 13, 2007;50(20):2018-2019.

3

Pellikka PA, Sarano ME, Nishimura RA, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation. June 21, 2005;111(24):3290-3295.

4

Charlson E, Legedza AT, Hamel MB. Decision-making and outcomes in severe symptomatic aortic stenosis. J Heart Valve Dis. May 2006;15(3):312-321.

5

Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. September 16, 2006;368(9540):1005-1011.

6

Lindroos M, Kupari M, Heikkilä J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol. April 1993;21(5):1220-1225.

7

Mack MJ, Brennan JM, Brindis R, et al. Outcomes following transcatheter aortic valve replacement in the United States. JAMA. November 20, 2013;310(19):2069-2077.

8

Medtronic data on file #1. 

9

lung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. July 2003;24(13):1231-1243. 

10

Bavaria JE. TAVR Update: New Insights and Perspectives from the U.S. National STS/ACC TVT Registry. Available from STS National Database.

11

Ross J Jr, Braunwald E. Aortic stenosis. Circulation. July 1968; 38(1 Suppl):61-67.

12

Carabello BA, Paulus WJ. Aortic stenosis. Lancet. March 14, 2009;373(9667):956-966.

13

McCarthy CP, Phelan D, Griffin B. When does asymptomatic aortic stenosis warrant surgery? Assessment techniques. Cleve Clin J Med. April 2016;83(4):271-280.

14

Brennan JM. Under-treatment of Aortic Stenosis in the United States. Presented at TVT 2019; Chicago, IL.

15

Medtronic data on file #2; ZS Research; 2019.

16

Schwarz F, Baumann P, Manthey J, et al. The effect of aortic valve replacement on survival. Circulation. November 1982;66(5):1105-1110. 

17

Active Living Awareness Initiative Survey. Survey included 3400 respondents. Available at: Heart-Valve-Surgery.com.